EGFR and cancer: The mechanism by which vitamin D reduces cancer risks has been attributed to the inhibition of cancer-promoting signaling pathways, including mutations in epidermal growth factor receptor (EGFR) and the dysregulation of Wnt/β-catenin, which determines proliferation and metastasis [8,42].